MELINDA DAVIS: Open Payments
NPI 1215346390 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,358 in 115 payments from 19 companies in 2025. Trend: 2023 $2,203 · 2024 $2,091 · 2025 $2,358
Food & beverage: $2,358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $290 |
| Esperion Therapeutics, Inc. | 10 | $260 |
| PFIZER INC. | 13 | $233 |
| Amgen Inc. | 9 | $226 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $196 |
| AstraZeneca Pharmaceuticals LP | 11 | $190 |
| Lilly USA, LLC | 8 | $176 |
| Exact Sciences Corporation | 7 | $152 |
| Lundbeck LLC | 7 | $140 |
| GlaxoSmithKline, LLC. | 5 | $93 |
Products named: NEXLETOL, EVENITY, VRAYLAR, XIFAXAN, REXULTI, JARDIANCE, PREVNAR 20, Cologuard Collection Kit.
Industry payments across CT — which companies pay providers there.
